Peer review reports
From: Insights from a community-based survey on factors influencing acceptance and uptake of Paxlovid (nirmatrelvir and ritonavir) as a COVID-19 antiviral medication in Singapore
Original Submission |
23 Feb 2024 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
22 Apr 2024 |
Reviewed |
Reviewer Report - Kah Shuen Thong
|
9 Jun 2024 |
Reviewed |
Reviewer Report
|
16 Jul 2024 |
Author responded |
Author comments - I-Cheng Mark Chen
|
Resubmission - Version 5 |
16 Jul 2024 |
Submitted |
Manuscript version 5
|
2 Aug 2024 |
Reviewed |
Reviewer Report
|
Resubmission - Version 6 |
|
Submitted |
Manuscript version 6
|
Publishing |
2 Aug 2024 |
Editorially accepted |
|
28 Aug 2024 |
Article published |
10.1186/s12889-024-19687-0
|
Learn about peer review